Zepbound News

GLP-1 weight loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are effective even at low starter doses. These drugs are initially prescribed at a low dose

A new Medicare pilot program offering GLP-1 medications for weight loss at $50 a month is excluding some patients, like Jeff La Marca, who have pre-existing con

GLP-1 drugs like Ozempic and Wegovy are revolutionizing obesity treatment by shifting focus to proactive management, but their high cost and unequal insurance c

Two weight-loss drugmakers, Novo Nordisk and Eli Lilly, are engaged in a legal battle over the effectiveness of their respective medications.

Novo Nordisk has sued rival Eli Lilly in a U.S. federal court, alleging false advertising regarding the efficacy of Lilly's weight-loss medicines compared to No

Novo Nordisk is suing Eli Lilly, alleging that its rival used "false and materially misleading" advertisements for its weight-loss and anti-diabetes treatments.